Taiko Pharmaceutical Co.,Ltd.
Taiko Pharmaceutical Co.,Ltd. (JPX: 4574) is trading at ¥254.00, about ₹155 at today's JPY/INR rate, as of 30 Sep 2026, 2:30 AM ET, down 0.78% today. Indian residents can buy Taiko Pharmaceutical from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
¥253.00
Today's high
¥260.00
52 week low
¥246.00
52 week high
¥317.00
4574 opened at ¥255.00, closed previously at ¥256.00, and has traded between ¥246.00 and ¥317.00 over the past 52 weeks.
About
Taiko Pharmaceutical Co.,Ltd. operates primarily in the pharmaceutical sector and the field of infection prevention. The company manufactures and distributes various over-the-counter medications, including its well-known Seirogan and Seirogan Toi-A brands, which are formulated to alleviate symptoms such as loose stools, diarrhea, vomiting, and ailments stemming from food or water contamination. Additionally, it provides specific tablets for diarrhea relief and quasi-pharmaceuticals like the Trumpet Intestinal Regulator BF. In its infection control segment, Taiko Pharmaceutical produces and supplies a range of sanitation products under the Cleverin brand to wholesalers. This includes the Cleverin generator, a device engineered to emit low concentrations of chlorine dioxide gas. The company also leverages its proprietary Cleverin technology by supplying it through original equipment manufacturer (OEM) agreements and engaging in joint product development ventures with other businesses. Its products are exported to several countries, including the United States, Canada, Thailand, Vietnam, Malaysia, and Mongolia. Taiko Pharmaceutical Co.,Ltd. was founded in 1946 and is headquartered in Osaka, Japan.
Key statistics
Avg. volume
105.10K
Market cap
¥12.76B
P/E Ratio
18.55
Price-to-sales ratio
1.93
Enterprise value
¥11.53B
Free cash flow yield
3.49%
Debt-to-equity ratio
0.02
Return on equity
10.84%
ROIC
4.19%
Beta
0.05
Dividend yield
1.30%
Last dividend
¥3.30
Financial overview
Revenue
¥6.40B
Earnings per share
¥18.37
Free cash flow
¥523.00M
Net profit margin
10.39%
Gross margin
52.85%
EBITDA
¥724.00M
Revenue growth
1.67%
Similar securities
This is not an investment recommendation
How to buy Taiko Pharmaceutical from India
Indian residents can buy Taiko Pharmaceutical shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars and then to JPY.
Search for Taiko Pharmaceutical and place an order
Find Taiko Pharmaceutical by name or by its ticker, 4574, and choose an order type. The Tokyo Stock Exchange typically trades in units of 100 shares. Taiko Pharmaceutical trades 5:30 am – 12:00 pm IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your Taiko Pharmaceutical position in JPY and INR, and use Paasa's capital-gains and dividend statements when you file your Indian return.
Read the full guide: how to invest in Taiko Pharmaceutical from India
Trading and taxes when buying Taiko Pharmaceutical from India
Trading and limits
- Trading hours
- 9:00 am – 3:30 pm JST
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- Slab rateDividends are taxed at your slab rate in India. Japan withholds a preferential 10% on dividends for Indian residents under the India–Japan DTAA rather than the higher domestic rate, and the tax withheld can be claimed as a foreign tax credit in India. Taiko Pharmaceutical’s current yield is 1.30%.Dividend tax explained
- Estate or inheritance tax
- May applyJapan levies inheritance tax on Japan-located assets such as direct stocks, with an exemption of ¥30 million plus ¥6 million per statutory heir.Estate tax explained
Custody. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
FAQs
Can Indian residents buy Taiko Pharmaceutical stock?
Yes. Taiko Pharmaceutical (4574) has been listed on the Tokyo Stock Exchange since 2009, in the Drug Manufacturers - Specialty & Generic industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars and then to JPY. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
How much does one Taiko Pharmaceutical share cost in rupees?
One Taiko Pharmaceutical share is ¥254.00 — about ₹155 at a JPY/INR rate of 0.6103 on 29 Sep 2026. Both the Taiko Pharmaceutical price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying Taiko Pharmaceutical from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
What is the minimum I can buy of Taiko Pharmaceutical?
The Tokyo Stock Exchange typically trades in units of 100 shares.
How are gains on Taiko Pharmaceutical shares taxed in India?
Japan generally does not levy capital gains tax on non-resident individual investors, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the JPY/INR rate on the purchase and the sale date, so the rupee move counts alongside the Taiko Pharmaceutical price. Paasa issues a capital-gains statement for your return.
Does Taiko Pharmaceutical pay a dividend, and how is it taxed in India?
Yes. Taiko Pharmaceutical pays a dividend and the current yield is 1.30%; the last declared dividend was ¥3.30 per share, about ₹2.01. Dividends are taxed at your slab rate in India. Japan withholds a preferential 10% on dividends for Indian residents under the India–Japan DTAA rather than the higher domestic rate, and the tax withheld can be claimed as a foreign tax credit in India. Paasa's dividend report lists the gross dividend and any tax withheld for each payment.
When can I trade Taiko Pharmaceutical from India?
The Tokyo Stock Exchange trades 5:30 am – 12:00 pm IST in Indian time. It also halts for lunch, 8:00 am – 9:00 am IST. Orders can only execute during that window.
Is there estate or inheritance tax on Taiko Pharmaceutical shares held from India?
Japan levies inheritance tax on Japan-located assets such as direct stocks, with an exemption of ¥30 million plus ¥6 million per statutory heir. It applies to your overall holdings in that jurisdiction rather than to any one position.
Do I have to declare Taiko Pharmaceutical shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Taiko Pharmaceutical holding, its cost and its closing value.
How do I sell Taiko Pharmaceutical and bring the money back to India?
You sell during market hours (5:30 am – 12:00 pm IST) and the proceeds settle in JPY in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.